Prostate Cancer - Results from #25220

Urologists and oncologists: Adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC) - Abstract August 6, 2012

Abiraterone for the treatment of metastatic castrate-resistant prostate cancer - Abstract August 6, 2012

Researchers discover new mechanism behind resistance to cancer treatment that could lead to better therapies August 6, 2012

Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy?: A systematic review - Abstract August 6, 2012

Vitamin D, PTH, and calcium and the risk of prostate cancer: A prospective nested case-control study - Abstract August 6, 2012

Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy - Abstract August 6, 2012

A molecular image-directed, 3D ultrasound-guided biopsy system for the prostate - Abstract August 6, 2012

Prostate cancer screening among ethnically diverse first-degree relatives of prostate cancer cases - Abstract August 6, 2012

Dietary patterns differ between urban and rural older, long-term survivors of breast, prostate, and colorectal cancer and are associated with body mass index - Abstract August 6, 2012

Use of radionuclides in metastatic prostate cancer: Pain relief and beyond - Abstract August 6, 2012

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study - Abstract August 6, 2012

Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram - Abstract August 6, 2012

Blood and tissue nitric oxide and malondialdehyde are prognostic indicators of localized prostate cancer - Abstract August 6, 2012

Coffee consumption and prostate cancer risk: Further evidence for inverse relationship - Abstract August 4, 2012

The role of genetic markers in the management of prostate cancer - Abstract August 4, 2012

Safety and preliminary efficacy analysis of the mTOR inhibitor Ridaforolimus in patients with taxane-treated, castration-resistant prostate cancer - Abstract August 4, 2012

ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasis - Abstract August 4, 2012

Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer - Abstract August 3, 2012

Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer - Abstract August 3, 2012

Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: Tamoxifen or radiotherapy? - Abstract August 3, 2012

Page 1262 of 1436